Literature DB >> 22788936

Anionic pulmonary surfactant lipid regulation of innate immunity.

Mari Numata, Pitchaimani Kandasamy, Dennis R Voelker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22788936      PMCID： PMC4444359          DOI： 10.1586/ers.12.21

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN： 1747-6348            Impact factor:   3.772


× No keyword cloud information.
  30 in total

Review 1.  The acute respiratory distress syndrome.

Authors:  L B Ware; M A Matthay
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

2.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors.

Authors:  A Ozinsky; D M Underhill; J D Fontenot; A M Hajjar; K D Smith; C B Wilson; L Schroeder; A Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 3.  Clinical practice. Prevention and treatment of seasonal influenza.

Authors:  W Paul Glezen
Journal:  N Engl J Med       Date:  2008-12-11       Impact factor: 91.245

4.  Pulmonary surfactant phosphatidylglycerol inhibits Mycoplasma pneumoniae-stimulated eicosanoid production from human and mouse macrophages.

Authors:  Pitchaimani Kandasamy; Simona Zarini; Edward D Chan; Christina C Leslie; Robert C Murphy; Dennis R Voelker
Journal:  J Biol Chem       Date:  2011-01-04       Impact factor: 5.157

5.  Phosphatidylglycerol suppresses influenza A virus infection.

Authors:  Mari Numata; Pitchaimani Kandasamy; Yoji Nagashima; Janelle Posey; Kevan Hartshorn; David Woodland; Dennis R Voelker
Journal:  Am J Respir Cell Mol Biol       Date:  2011-11-03       Impact factor: 6.914

6.  A dipalmitoylated lipoprotein from Mycoplasma pneumoniae activates NF-kappa B through TLR1, TLR2, and TLR6.

Authors:  Takashi Shimizu; Yutaka Kida; Koichi Kuwano
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

7.  Altered airway surfactant phospholipid composition and reduced lung function in asthma.

Authors:  S M Wright; P M Hockey; G Enhorning; P Strong; K B Reid; S T Holgate; R Djukanovic; A D Postle
Journal:  J Appl Physiol (1985)       Date:  2000-10

8.  Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.

Authors:  E A Kurt-Jones; L Popova; L Kwinn; L M Haynes; L P Jones; R A Tripp; E E Walsh; M W Freeman; D T Golenbock; L J Anderson; R W Finberg
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

9.  Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection.

Authors:  Mari Numata; Hong Wei Chu; Azzeddine Dakhama; Dennis R Voelker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

Review 10.  Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation.

Authors:  Yi Y Zuo; Ruud A W Veldhuizen; A Wilhelm Neumann; Nils O Petersen; Fred Possmayer
Journal:  Biochim Biophys Acta       Date:  2008-04-08
View more
  14 in total

1.  Phosphatidylinositol inhibits respiratory syncytial virus infection.

Authors:  Mari Numata; Pitchaimani Kandasamy; Yoji Nagashima; Rachel Fickes; Robert C Murphy; Dennis R Voelker
Journal:  J Lipid Res       Date:  2015-01-05       Impact factor: 5.922

Review 2.  Understanding phospholipid function: Why are there so many lipids?

Authors:  William Dowhan
Journal:  J Biol Chem       Date:  2017-05-10       Impact factor: 5.157

Review 3.  Surfactant Lipids at the Host-Environment Interface. Metabolic Sensors, Suppressors, and Effectors of Inflammatory Lung Disease.

Authors:  Michael B Fessler; Ross S Summer
Journal:  Am J Respir Cell Mol Biol       Date:  2016-05       Impact factor: 6.914

4.  Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection.

Authors:  Mari Numata; Yoji Nagashima; Martin L Moore; Karin Z Berry; Mallory Chan; Pitchaimani Kandasamy; R Stokes Peebles; Robert C Murphy; Dennis R Voelker
Journal:  J Lipid Res       Date:  2013-06-06       Impact factor: 5.922

5.  Identification of oxidized phospholipids in bronchoalveolar lavage exposed to low ozone levels using multivariate analysis.

Authors:  Ann-Charlotte Almstrand; Dennis Voelker; Robert C Murphy
Journal:  Anal Biochem       Date:  2015-01-07       Impact factor: 3.365

6.  Structural analogs of pulmonary surfactant phosphatidylglycerol inhibit toll-like receptor 2 and 4 signaling.

Authors:  Pitchaimani Kandasamy; Mari Numata; Karin Zemski Berry; Rachel Fickes; Christina C Leslie; Robert C Murphy; Dennis R Voelker
Journal:  J Lipid Res       Date:  2016-04-19       Impact factor: 5.922

7.  Pulmonary surfactant lipids inhibit infections with the pandemic H1N1 influenza virus in several animal models.

Authors:  Mari Numata; James R Mitchell; Jennifer L Tipper; Jeffrey D Brand; John E Trombley; Yoji Nagashima; Pitchaimani Kandasamy; Hong Wei Chu; Kevin S Harrod; Dennis R Voelker
Journal:  J Biol Chem       Date:  2019-12-27       Impact factor: 5.157

Review 8.  Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids.

Authors:  Mari Numata; Dennis R Voelker
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2022-02-28       Impact factor: 5.228

Review 9.  Lipid-Protein and Protein-Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis.

Authors:  Olga Cañadas; Bárbara Olmeda; Alejandro Alonso; Jesús Pérez-Gil
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

10.  Phosphatidylglycerol Incorporates into Cardiolipin to Improve Mitochondrial Activity and Inhibits Inflammation.

Authors:  Wei-Wei Chen; Yu-Jen Chao; Wan-Hsin Chang; Jui-Fen Chan; Yuan-Hao Howard Hsu
Journal:  Sci Rep       Date:  2018-03-20       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.